Cargando…

Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial

AIMS: Previous uncontrolled studies suggested a possible benefit of intravenous immunoglobulin (IVIg) in parvovirus B19 (B19V)‐related dilated cardiomyopathy (DCM). This randomized, double‐blind, placebo‐controlled, single‐centre trial investigated the benefits of IVIg beyond conventional therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hazebroek, Mark R., Henkens, Michiel T.H.M., Raafs, Anne G., Verdonschot, Job A.J., Merken, Jort J., Dennert, Robert M., Eurlings, Casper, Abdul Hamid, Myrurgia A., Wolffs, Petra F.G., Winkens, Bjorn, Brunner‐La Rocca, Hans‐Peter, Knackstedt, Christian, van Paassen, Pieter, van Empel, Vanessa P.M., Heymans, Stephane R.B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2021
Materias:	Focus on Myocarditis, Cardiomyopathy and Amyloidosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048650/ https://www.ncbi.nlm.nih.gov/pubmed/33347677 http://dx.doi.org/10.1002/ejhf.2082

Ejemplares similares

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study
por: Damy, Thibaud, et al.
Publicado: (2020)

A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
por: Verdonschot, Job A.J., et al.
Publicado: (2021)

Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under‐diagnosed disease
por: Prastaro, Maria, et al.
Publicado: (2022)

The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
por: Raafs, Anne G., et al.
Publicado: (2021)

Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study
por: Raafs, Anne G., et al.
Publicado: (2023)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Ventriculoseptal Rupture Caused by Takotsubo Syndrome
por: Sternberg, Michael E., et al.
Publicado: (2020)

Left Ventricular Assist Device With a Left Atrial Inflow Cannula for Hypertrophic Cardiomyopathy
por: Kiamanesh, Omid, et al.
Publicado: (2020)

Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy: The Importance of Cardiac Magnetic Resonance Imaging
por: Feldman, Daniel R., et al.
Publicado: (2020)

Early-Onset of Transthyretin Amyloidosis in a Young Afro-Caribbean Woman With Thr60Ala Mutation
por: Keppel, Stormy C., et al.
Publicado: (2020)

Thebesian Veins Draining to the Left Ventricle, Mimicking Left Ventricular Noncompaction
por: Stämpfli, Simon F., et al.
Publicado: (2020)

All-trans Retinoic Acid–Induced Isolated Myocarditis: A Case Report and Review of the Literature
por: Karakulak, Ugur Nadir, et al.
Publicado: (2020)

Carcinoid Crisis–Induced Acute Systolic Heart Failure
por: Maddali, Manoj V., et al.
Publicado: (2020)

Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy
por: Jacob, Robin, et al.
Publicado: (2020)

A Rare Case of Severe Nontropical Isolated Right Ventricular Endomyocardial Fibrosis
por: Laher, Shaaheen, et al.
Publicado: (2020)

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Transthyretin Cardiac Amyloidosis: A Noninvasive Multimodality Approach to Diagnosis Using Transthoracic Echocardiography, 99m-Tc-Labeled Phosphate Bone Scanning, and Cardiac Magnetic Resonance Imaging
por: Shukla, Akhil, et al.
Publicado: (2017)

Regression of the Anatomic Cardiac Features of Amyloid Light Chain Cardiac Amyloidosis Accompanied by Normalization of Global Longitudinal Strain
por: Fitzgerald, Benjamin T., et al.
Publicado: (2017)

An Autopsy Case of Cardiac Amyloidosis with Heterogeneous Deposition of Amyloid Protein: A Possible Mechanism for Relative Apical Sparing of Longitudinal Strain
por: Sawada, Naoko, et al.
Publicado: (2019)

Systemic embolism in amyloid transthyretin cardiomyopathy
por: Vilches, Silvia, et al.
Publicado: (2022)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
por: Aimo, Alberto, et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Value of the HFA‐PEFF and H(2)FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis
por: Patel, Rishi K., et al.
Publicado: (2022)

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients
por: Raafs, Anne G., et al.
Publicado: (2022)

Differences in virus prevalence and load in the hearts of patients with chronic dilated cardiomyopathy with and without immune-mediated inflammatory disease
por: Dennert, R, et al.
Publicado: (2010)

Balance of Active, Passive, and Anatomical Cardiac Properties in Doxorubicin-Induced Heart Failure
por: Lewalle, Alexandre, et al.
Publicado: (2019)

Clinical aspects of virus/immune myocarditis
por: O'Connell, John B., et al.
Publicado: (1985)

The HFA‐PEFF and H(2)FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction
por: Sanders‐van Wijk, Sandra, et al.
Publicado: (2020)

Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood
por: Russcher, Anne, et al.
Publicado: (2021)

Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies
por: Hazebroek, M., et al.
Publicado: (2012)

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)

OP4-4 Prevalence, quantification and cut-off level of parvovirus B19 DNA in endomyocardial biopsies of cardiac patients and non-cardiac control subjects
por: Goossens, V.J., et al.
Publicado: (2009)

Desmin Mutations and Arrhythmogenic Right Ventricular Cardiomyopathy
por: Lorenzon, Alessandra, et al.
Publicado: (2013)

Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy
por: Patel, Vimal, et al.
Publicado: (2014)

Myofibrillar Cardiomyopathy due to a Novel Desmin Gene Mutation: Complementary Role of Echocardiography, Cardiac Magnetic Resonance, and Genetic Testing in Delineating Diagnosis
por: Koitka, Karen, et al.
Publicado: (2017)

Cough-Induced Takotsubo (Stress) Cardiomyopathy
por: Lal, Sudish, et al.
Publicado: (2018)

The left atrium in cardiac amyloidosis: a valuable but still underused observation window on the overall disease process
por: Rapezzi, Claudio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cft1p56llhchimh8aafel2j6qo